Biocidin Academy

News

FEATURED

Health Consequences of Mold and Mycotoxin Exposure Part 3: Intervention Options

Read more

Articles

Here you’ll find a growing body of knowledge researched and written by our clinical staff and by key educational partners.

PRO Health Consequences of Mold and Mycotoxin Exposure Part 3: Intervention Options

Health Consequences of Mold and Mycotoxin Exposure Part 3: Intervention Options

This article will profile certain compounds used for direct mold intervention, as well as mycotoxin elimination. The following information is not meant to be an exhaustive list of all variables regarding intervention but instead focuses on some of the more commonly used remedies. Also, please be aware that the science behind mold and mycotoxin intervention is evolving, and various skilled practitioners may have differing opinions and methods.

Learn More

PRO What Bugs Your Heart?

What Bugs Your Heart?

Almost half of all adults in the US are impacted by cardiovascular disease (CVD). That's the bad news. The good news is risk factors can be mitigated. This article considers the role of microbiota and their metabolites and the benefits of a flourishing, healhy microbiome in supporting excellent health and lowering the risk of CVD.

Learn More

PRO Candidiasis Part I: Pathogenicity Mechanisms

Candidiasis Part I: Pathogenicity Mechanisms

Gastrointestinal candidiasis (GC) is well-known to functional and integrative medicine providers. In this article, Kurt Woeller, DO, discusses various aspects of chronic candidiasis as it relates to different health conditions and explores different mechanisms of pathogenicity including arabinose toxicity, leaky gut (intestinal permeability), invasive protein, and immune deficiency.

Learn More

PRO Candidiasis Part 2: Laboratory Testing Options

Candidiasis Part 2: Laboratory Testing Options

Blood cultures for Candida, unfortunately, are often unreliable. Based on years of clinical experience, Kurt Woeller, DO, outlines laboratory test options for the detection of intestinal candida, as well as effective methods for analyzing the invasive nature of these fungal organisms.

Learn More

PRO Candidiasis Part 3: Treatment Options

Candidiasis Part 3: Treatment Options

Invasive Candida. What can be done about it? Kurt Woeller, DO, discusses three distinct categories of intervention: systemic, non-systemic, and botanical. He specifically explores two antifungal medications and five botanicals known to be helpful in addressing chronic candidiasis.

Learn More

PRO Clinical Considerations of Chronic Lyme Part I: Pathophysiology

Clinical Considerations of Chronic Lyme Part I: Pathophysiology

Lyme and tick-borne illnesses are complex and challenging. To assist in patient evaluation, Emily Hernandez, ND, a Lyme-literate doctor and Biocidin® Clinical Consultant, provides a thorough overview of current thinking in the field, as well as symptom pictures, acute vs. chronic conditions, and common co-infections.

Learn More

PRO Chronic Lyme Part 2: Testing and Diagnosis

Chronic Lyme Part 2: Testing and Diagnosis

Lyme is known as “The Great Imitator” because of its variety and complexity. Emily Hernandez, ND, a Lyme specialist, brings clarity to testing options to help practitioners identify when Lyme and its coinfections are the root cause of illness.

Learn More